Innovacell Inc. 504AShort Interest
No institution currently reports a short position of 0.5% or more in Innovacell Inc. (504A). The last disclosure was on 2026-08-25 (Morgan Stanley MUFG Securities Co., Ltd., 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
14 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 2 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2026-02-24 |
|---|---|
| Latest disclosure | 2026-08-25 (Morgan Stanley MUFG Securities Co., Ltd., 0.49%) |
| Reporting institutions | 3 firms (14 reports) |
| Peak estimated short interest | 5.94% (2026-02-26, 1 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 3 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Nomura Securities Co., Ltd.
- Morgan Stanley MUFG Securities Co., Ltd.
- GOLDMAN SACHS INTERNATIONAL
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-08-25 | Morgan Stanley MUFG Securities Co., Ltd. | Position 222,561 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-07-02 | GOLDMAN SACHS INTERNATIONAL | Position 220,124 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2026-03-19 | Nomura Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼2.49% | Closed |
Disclosure History 14 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-08-25 | Morgan Stanley MUFG Securities Co., Ltd. | Position 222,561 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-08-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 226,961 shares | Ratio 0.50% | ▲0.02% | — |
| 2026-08-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 217,961 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-08-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 265,961 shares | Ratio 0.58% | ▼0.02% | — |
| 2026-07-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 275,161 shares | Ratio 0.60% | ▲0.07% | — |
| 2026-07-29 | Morgan Stanley MUFG Securities Co., Ltd. | Position 239,461 shares | Ratio 0.53% | ▲0.13% | — |
| 2026-07-02 | GOLDMAN SACHS INTERNATIONAL | Position 220,124 shares | Ratio 0.48% | ▼0.05% | Below 0.5% |
| 2026-06-26 | GOLDMAN SACHS INTERNATIONAL | Position 223,924 shares | Ratio 0.53% | ▲0.10% | — |
| 2026-03-19 | Nomura Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼2.49% | Closed |
| 2026-03-16 | Nomura Securities Co., Ltd. | Position 1,041,600 shares | Ratio 2.49% | ▼0.09% | — |
| 2026-03-03 | Nomura Securities Co., Ltd. | Position 1,080,200 shares | Ratio 2.58% | ▼0.06% | — |
| 2026-02-27 | Nomura Securities Co., Ltd. | Position 1,102,200 shares | Ratio 2.64% | ▼3.30% | — |
| 2026-02-26 | Nomura Securities Co., Ltd. | Position 2,482,900 shares | Ratio 5.94% | ▲3.19% | — |
| 2026-02-24 | Nomura Securities Co., Ltd. | Position 1,151,200 shares | Ratio 2.75% | ▲2.75% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PRISM BioLab Co.,LTD206A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| K Pharma,Inc.4896 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |